{"id":4373,"date":"2016-09-20T09:36:04","date_gmt":"2016-09-20T13:36:04","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4373"},"modified":"2016-09-20T09:36:04","modified_gmt":"2016-09-20T13:36:04","slug":"as-profitable-fentanyl-industry-expands-in-china-us-negotiates-to-halt-the-deadly-trade","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4373","title":{"rendered":"As profitable fentanyl industry expands in China, US negotiates to halt the deadly trade"},"content":{"rendered":"<p>(By Kathleen McLaughlin for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">B<\/span>EIJING \u2014 Top American and Chinese enforcement officials are negotiating how to fight the rampant trade in synthetic drugs manufactured here and blamed for a <a href=\"https:\/\/www.statnews.com\/2016\/04\/05\/fentanyl-traced-to-china\/\" target=\"_blank\">deadly wave of spiked opioids<\/a><sup class=\"footnote\">1<\/sup> in the United States. <a href=\"https:\/\/www.statnews.com\/2016\/09\/20\/china-fentanyl-industry\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"stat-logo\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Kathleen McLaughlin for STAT) BEIJING \u2014 Top American and Chinese enforcement officials are negotiating how to fight the rampant<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-4373","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4373"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4373\/revisions"}],"predecessor-version":[{"id":4374,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4373\/revisions\/4374"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}